Articles tagged with Type 1 Diabetes
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers at UNC School of Medicine used injections of non-depleting antibodies to rapidly reverse the onset of Type I diabetes in mice. The treatment maintained disease remission indefinitely without harming the immune system, with some animals remaining free of diabetes after over 400 days.
A new study found that adding liraglutide to insulin therapy improves blood sugar control in obese adults with poorly controlled Type 1 diabetes. Patients also experienced significant weight loss and lower blood pressure.
Scientists at Joslin Diabetes Center have identified a new cause of cardiac damage after heart attacks in people with type 1 diabetes. A runaway autoimmune response triggered by alpha-myosin leads to chronic inflammation, cardiomyopathy, and heart failure. The study offers promising targets for future interventions to protect the heart.
A study by Joslin Diabetes Center found that a significant number of people with long-term type 1 diabetes developed little to no diabetic eye disease over time. The researchers hope to identify the factors behind this protection, which could lead to new treatments or prevention strategies.
The Hypoglycemia-Hyperglycemia Minimizer (HHM) System successfully detects blood glucose highs and lows, automatically adjusting insulin delivery to safely manage type 1 diabetes. The study's findings lay the groundwork for further clinical trials and a potential game-changer for millions living with the condition.
Scientists at the Toronto General Hospital Research Institute showed that an experimental bariatric surgery can lower blood sugar levels in non-obese rats with type 1 diabetes. The study demonstrated that duodenal-jejunal bypass surgery activates novel nutrient-sensing signals in the jejunum, rapidly lowering blood sugar levels.
A clinical study demonstrates the effectiveness of an automated insulin dosage titration system in improving blood glucose control and reducing hypoglycemic events. The system, developed by Hygieia, Inc., automatically updates insulin dosage for patients with type 2 or type 1 diabetes, leading to improved glycemic targets.
Researchers have identified significant differences in how diabetes affects Asian populations, including unique markers for type 1 diabetes diagnosis. The study highlights the need for culturally sensitive care, tailored treatment guidelines, and expanded education programs.
The iDEAL study is a Phase II clinical trial evaluating the safety and efficacy of iCo-007 in treating diabetic macular edema. The trial aims to improve visual acuity in patients with DME, a leading cause of blindness in working Americans.
Scientists discover that cellular stress takes place in pancreatic beta cells before T1D onset, potentially igniting autoimmune attack. ER stress response may contribute to beta cell dysfunction and death, shedding light on disease progression and potential therapeutic targets.
Researchers have developed a personalized immune mouse that can recreate an individual's immune system, allowing for unprecedented analysis of abnormalities contributing to type 1 diabetes and other autoimmune diseases. This model has the potential to develop individualized immunotherapies against cancer and infection.
A new JDRF-funded study identifies genes expressed in beta cells, suggesting a role in their own destruction leading to T1D. The research may help explain why the immune system specifically attacks beta cells, opening up new avenues for understanding and treating the disease.
A study from Massachusetts General Hospital found that C-peptide production persists for decades after Type 1 diabetes onset, and beta cell functioning remains intact at low levels. The novel ultrasensitive assay detected C-peptide in 34 of 54 blood samples, suggesting a longer window for therapeutic intervention.
Scientists studied children with newly diagnosed type 1 diabetes to understand its initial stages. They found variability in T-regulatory cell activity and increased immune-boosting cells, which may help develop new treatments.
A study found that automatic suspension of insulin delivery via insulin pumps reduces the severity and duration of hypoglycemia in individuals with type 1 diabetes. The 'low glucose suspend' feature significantly decreases hypoglycemic episodes, reducing the risk of rebound hyperglycemia.
A recent study suggests that seasonal variations in the immune system may impact the effectiveness of a vaccine targeting type 1 diabetes. The vaccine, which uses the GAD65 antigen, showed promise in earlier trials but failed to demonstrate significant effects in its latest phase 3 trial. The study's authors propose that factors such a...
Scientists at Joslin Diabetes Center identified two novel markers that can predict renal failure in patients with Type 1 and Type 2 diabetes, ten years in advance. High concentrations of TNFR1 and TNFR2 accurately predict the risk of renal function loss.
Researchers at Cardiff University have discovered a link between killer T-cells and the development of Type 1 diabetes. The study found that killer T-cells can attack and destroy insulin-producing cells in the pancreas, leading to a lack of insulin and high blood sugar.
Researchers at La Jolla Institute identified specific T cells that trigger type 1 diabetes in humans for the first time in human tissues. The study provides a crucial step in interrupting the disease process and highlights CD8 T cells as key players.
Researchers have discovered a protein called Islet Homeostasis Protein (IHoP) that regulates blood sugar levels by balancing insulin and glucagon. The protein's presence helps maintain healthy glucose levels, while its absence leads to increased glucagon and insulin resistance.
The REMOVAL study aims to test whether metformin can prevent or reduce the risk of cardiovascular complications in people with type 1 diabetes. The five-year trial will follow 500 patients and examine the effects of metformin on blood glucose control, treatment satisfaction, and other complications.
Researchers at Joslin Diabetes Center have identified a critical diagnostic marker that differentiates type 1 from type 2 diabetes in young Asian Americans, highlighting the importance of insulin resistance. The study also found physical differences in Asian patients with diabetes that should inform treatment recommendations.
Researchers at La Jolla Institute create cellular movies showing the destruction underlying type 1 diabetes in real-time, providing new insights into disease process and potential therapeutic directions. The studies use two-photon microscope to illuminate cell processes previously extrapolated from photos or lab experiments.
A long-term study found that early, intensive glucose-lowering therapy in type 1 diabetes patients prevented impaired glomerular filtration rates and reduced the risk of end-stage kidney disease. Participants who received intensive therapy showed a 50% lower risk of developing impaired GFR over a median follow-up period of 22 years.
Researchers found that intensive diabetes therapy can preserve kidney function in patients with type 1 diabetes, preventing impaired kidney function and kidney failure. The study's results demonstrate the importance of maintaining good glucose control early in the course of type 1 diabetes to prevent long-term kidney complications.
Researchers found that connexin 36 protects mouse pancreatic beta-cells against apoptosis triggered by immune molecules prevalent at the onset of Type 1 diabetes. Promoting connexin 36 expression and function could provide a therapeutic strategy to protect beta-cells from immune system attack.
A $3.9 million grant will enable research to identify protective factors that prevent diabetes complications in long-term insulin-dependent diabetes patients. The study aims to find biomarkers and therapeutic agents to halt diabetic retinopathy and nephropathy, which significantly impact lifespan and quality of life.
Researchers discover a compound that prevents Type 1 diabetes in mice and has similar effects on human cells from diabetic patients. The finding signals a new direction in fighting the disease and other autoimmune disorders.
A group of international diabetes researchers have been awarded $4.5 million to engineer an artificial pancreas system that can monitor and adapt to the body's complex physiological changes. The system aims to improve quality of life for patients with type 1 diabetes by treating the condition in their natural environment.
Researchers have identified a non-classical form of fetal immune thrombocytopenia that can lead to miscarriage and habitual abortion. The condition is characterized by excessive platelet activation and blood clot formation in the placenta. New treatments targeting this condition have been suggested, offering hope for women affected by it.
The University of California San Diego is awarded a $5.9 million grant to study kidney complications related to type 1 and type 2 diabetes. The researchers aim to challenge current dogma by examining the link between mitochondrial function, metabolic alterations, and kidney disease.
A large-scale genetic study has uncovered new genes associated with type 1 diabetes, a condition affecting 200 million people worldwide. The research adds to knowledge of gene networks involved in the origin of this complex disorder.
Hebrew University researchers have identified a key signal that prompts production of insulin-producing beta cells, which may help restore or increase beta cell function in people with type 1 diabetes. The study found that glucose levels trigger the regeneration of beta cells through a specific enzyme, glucokinase.
A study by Dr Jay S Skyler and colleagues found that abatacept slows the loss of insulin-producing beta-cells in type 1 diabetes patients, but only for the first six months. The treatment helps modulate T-cell activation, resulting in higher C-peptide levels.
Researchers at St. Michael's Hospital discovered that GABA injections prevented and reversed Type 1 diabetes in mice by regenerating insulin-producing cells and decreasing the immune system's attack on them. This breakthrough finding offers new avenues for prevention and treatment of Type 1 diabetes.
Researchers found that a strawberry a day may keep doctors away, including neurologists, endocrinologists, and oncologists. Fisetin, a flavonoid compound, reduced complications of diabetes, anxiety-related behaviors, and high blood sugar levels in mice.
A vaccine targeting glutamic acid decarboxylase (GAD) failed to preserve insulin production in patients with newly diagnosed type 1 diabetes. Researchers suggest that the vaccine may be beneficial for preventing or delaying the onset of the disease, but should not be used in clinical practice.
Researchers have found that low doses of BCG can temporarily reverse type 1 diabetes in human patients by eliminating autoreactive T cells. A Phase II trial is now underway to test the effectiveness of this approach.
Mayo Clinic researchers are developing an artificial pancreas that will deliver insulin automatically and with individualized precision, reducing the need for daily insulin dosing and finger pricks. The system includes a blood sugar monitor, automatic insulin pump, activity monitors, and a central processing unit.
Research finds that adolescents and young adults with type 1 diabetes have increased risk of heart attack and stroke due to atherosclerosis in the carotid arteries. The study aims to improve glycemic control and reduce cardiovascular risk factors to prevent cardiovascular disease.
A new study found that people diagnosed with type 1 diabetes can expect to live up to 15 years longer than previously thought. The study, published in the American Diabetes Association's 71st Scientific Sessions, analyzed data from a 30-year prospective study and found a significant improvement in life expectancy among participants.
The DIAPREV-IT study, a three-year project funded by the Juvenile Diabetes Research Foundation, aims to vaccinate healthy children at high risk of developing type 1 diabetes. The researchers believe that vaccinating earlier in the disease process can save more beta cells and increase the vaccine's effectiveness.
Researchers at Rensselaer Polytechnic Institute have created a closed-loop artificial pancreas that can automatically monitor blood sugar levels and administer insulin to individuals with Type 1 diabetes. The device aims to reduce the guesswork involved in daily insulin management, which is crucial for maintaining stable glucose levels.
Georgia Health Sciences University researchers are exploring whether low levels of interleukin-1 receptor antagonist (IL-1ra) can identify children at risk for developing type 1 diabetes. They also plan to investigate using IL-1 inhibitors to prevent the disease.
Despite significant advances in kidney care, type 1 diabetes patients with kidney dysfunction continue to face increased risks of kidney failure and heart-related death. New therapies are needed to retard progression to end-stage renal disease.
Researchers analyzed data from 592 patients with type 1 diabetes and macroalbuminuria to identify predictors of End-Stage Renal Disease (ESRD) and pre-ESRD mortality. The study found that poor glycemic control increases ESRD risk but not pre-ESRD mortality, while improved lipid management affects both outcomes.
Researchers at the Medical College of Wisconsin found that children with type 1 diabetes often develop early cardiovascular disease before puberty, characterized by stiffer blood vessels and vascular inflammation. The study highlights the need for long-term studies to monitor the progression of these changes in young patients.
The European Diabetes Research Network, funded by the EU, will investigate the possible role of virus infection in causing type 1 diabetes. The network aims to develop a vaccine to prevent diabetes in children and improve diagnosis and patient care.
UT Southwestern researchers found that eliminating glucagon action can restore glucose tolerance to normal in mice with type 1 diabetes. This suggests a potential 'cure' for the disease, as insulin would no longer be necessary.
A La Jolla Institute team has validated a computer model's ability to predict key information on nasal insulin treatment regimens in type 1 diabetes. The platform accurately predicted biomarker onset and therapeutic outcome, confirming its potential as a valuable research tool.
A Finnish study found that infant feeding with a highly hydrolyzed casein-based formula reduced the emergence of diabetes-predictive autoantibodies by about 50% among high-risk children. The study suggests that early dietary intervention can substantially reduce the initiation of the disease process leading to Type 1 diabetes.
Researchers used selective breeding of mice to identify a novel gene, AK005651, associated with type 1 diabetes susceptibility. A recombination hotspot helped stack the DNA deck in favor of finding this gene, revealing new clues about genomic mechanisms underlying T1D.
Researchers at UT Southwestern Medical Center found that infusing leptin into the brain of mice with type 1 diabetes reversed lethal consequences and improved metabolism. The study suggests a novel role for the brain in mediating beneficial actions of leptin, potentially leading to new therapies for individuals with type 1 diabetes.
A UBC-CFRI study found elevated levels of Th17 cells in young patients with type 1 diabetes, suggesting a potential target for new therapies. The discovery may lead to innovative treatments for childhood diabetes.
A crowdsourcing experiment, called the Challenge, has selected 12 pioneering ideas for attacking Type 1 Diabetes. These ideas were proposed by a diverse group of people, including patients, students, and researchers from various backgrounds.
UC San Diego researcher Maike Sander leads a team in developing replacement insulin-producing beta cells from patient-derived induced pluripotent stem cells. The goal is to create a cell-based approach for treating type 1 diabetes, providing patients with insulin independence and reduced risk of hypoglycemia.
A multi-center team of scientists from OHSU is part of the prestigious Beta Cell Biology Consortium, aiming to develop a cell-based therapy for insulin delivery in type 1 diabetes patients. The researchers hope to produce abundant quantities of functional human insulin-producing beta cells that can be used for transplantation.
Novo Nordisk's decision to withdraw Mixtard 30 insulin could add £9 million to the NHS drugs bill in England, affecting 90,000 patients with type 1 and 2 diabetes. Alternative biphasic insulins are more expensive and may cause disruption to patient care.
Researchers found that adding a continuous blood sugar sensor to an insulin pump improved blood sugar control, with significant decreases in A1c levels and no increase in severe hypoglycemia. The study's findings suggest that this technology can help patients of all ages manage their diabetes effectively.
The Phase I trial found low-dose, multi-dosing regimens of BCG vaccination safe in individuals with type 1 diabetes, with no severe reactions reported. A Phase II clinical trial is planned to investigate the safety and efficacy of BCG vaccination as a therapeutic agent for type 1 diabetes prevention or reversal.